CCA Approves SA’s Abovax to Buy 60% of MRI Botswana

15 February 2024

The Competition and Consumer Authority (CCA) has approved the purchase of 60% equity in MRI Botswana by the South African health services group, Abovax.

Currently, MRI is owned by Botswana Medical Aid (Bomaid), the Motor Vehicle Accident Fund, and individuals. Bomaid, through its investment arm, Southview, holds the majority stake of MRI at 94%, whilst MVA Fund owns 4% and the individual shareholders account for the balance. In a notice last week, the CCA said its assessment had not shown any competition issues in the transaction.

The company is a multi-faceted healthcare services provider with five core business units: Emergency Medical Services (EMS), general medical services, pharmacies, a training academy, and a contact centre. 

EMS focuses on pre-hospital emergency care and patient transportation, whilst the general medical services unit manages Prime Health clinics and occupational healthcare facilities. The pharmacies offer courier services and innovative Collect & Go technology lockers for medication distribution.

The training academy caters to MRI’s internal medical training needs, and the contact centre provides outsourced services such as care lines and counselling. Furthermore, MRI has been providing services to three of the country’s top four medical aids.

Source: https://rb.gy/jgjtnt

1 month ago

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.